tiprankstipranks
Trending News
More News >
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
India Market

Krebs Biochemicals & Industries Ltd. (KREBSBIO) Price & Analysis

Compare
0 Followers

KREBSBIO Stock Chart & Stats

₹69.23
-₹2.80(-2.89%)
At close: 4:00 PM EST
₹69.23
-₹2.80(-2.89%)

KREBSBIO FAQ

What was Krebs Biochemicals & Industries Ltd.’s price range in the past 12 months?
Krebs Biochemicals & Industries Ltd. lowest stock price was ₹61.22 and its highest was ₹113.90 in the past 12 months.
    What is Krebs Biochemicals & Industries Ltd.’s market cap?
    Krebs Biochemicals & Industries Ltd.’s market cap is ₹1.51B.
      When is Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date?
      Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date is Feb 02, 2026 which is in 39 days.
        How were Krebs Biochemicals & Industries Ltd.’s earnings last quarter?
        Krebs Biochemicals & Industries Ltd. released its earnings results on Nov 04, 2025. The company reported -₹2.849 earnings per share for the quarter, missing the consensus estimate of N/A by -₹2.849.
          Is Krebs Biochemicals & Industries Ltd. overvalued?
          According to Wall Street analysts Krebs Biochemicals & Industries Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Krebs Biochemicals & Industries Ltd. pay dividends?
            Krebs Biochemicals & Industries Ltd. does not currently pay dividends.
            What is Krebs Biochemicals & Industries Ltd.’s EPS estimate?
            Krebs Biochemicals & Industries Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Krebs Biochemicals & Industries Ltd. have?
            Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding.
              What happened to Krebs Biochemicals & Industries Ltd.’s price movement after its last earnings report?
              Krebs Biochemicals & Industries Ltd. reported an EPS of -₹2.849 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.298%.
                Which hedge fund is a major shareholder of Krebs Biochemicals & Industries Ltd.?
                Currently, no hedge funds are holding shares in IN:KREBSBIO
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Krebs Biochemicals & Industries Ltd.

                  Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

                  Krebs Biochemicals & Industries Ltd. (KREBSBIO) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aarey Drugs & Pharmaceuticals Ltd.
                  Alpa Laboratories Limited
                  Bafna Pharmaceuticals Limited
                  Bal Pharma Limited
                  Vaishali Pharma Ltd.
                  Popular Stocks